BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 15885953)

  • 1. Cochlin in normal middle ear and abnormal middle ear deposits in DFNA9 and Coch (G88E/G88E) mice.
    Robertson NG; O'Malley JT; Ong CA; Giersch AB; Shen J; Stankovic KM; Morton CC
    J Assoc Res Otolaryngol; 2014 Dec; 15(6):961-74. PubMed ID: 25049087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel COCH mutation associated with autosomal dominant nonsyndromic hearing loss disrupts the structural stability of the vWFA2 domain.
    Cho HJ; Park HJ; Trexler M; Venselaar H; Lee KY; Robertson NG; Baek JI; Kang BS; Morton CC; Vriend G; Patthy L; Kim UK
    J Mol Med (Berl); 2012 Nov; 90(11):1321-1331. PubMed ID: 22610276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of a genomically humanized mouse model for dominantly inherited hearing loss, DFNA9.
    Verdoodt D; van Wijk E; Broekman S; Venselaar H; Aben F; Sels L; De Backer E; Gommeren H; Szewczyk K; Van Camp G; Ponsaerts P; Van Rompaey V; de Vrieze E
    Hear Res; 2024 Feb; 442():108947. PubMed ID: 38218018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel
    Peng Y; Xiang M; Fan T; Zhong X; Dai A; Feng J; Guan P; Gong J; Li J; Wang Y
    Life (Basel); 2023 Dec; 14(1):. PubMed ID: 38255649
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of cochlin binding to sulfated heparan sulfate/heparin in the pathophysiology of autosomal dominant late-onset hearing loss (DFNA9).
    Honda T; Kawasaki N; Yanagihara R; Tamura R; Murakami K; Ichimiya T; Matsumoto N; Nishihara S; Yamamoto K
    PLoS One; 2022; 17(7):e0268485. PubMed ID: 35901072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochlin Deficiency Protects Against Noise-Induced Hearing Loss.
    Seist R; Landegger LD; Robertson NG; Vasilijic S; Morton CC; Stankovic KM
    Front Mol Neurosci; 2021; 14():670013. PubMed ID: 34108864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-Phenotype Correlations of Pathogenic
    Robijn SMM; Smits JJ; Sezer K; Huygen PLM; Beynon AJ; van Wijk E; Kremer H; de Vrieze E; Lanting CP; Pennings RJE
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing of exons 4, 5, 12 of COCH gene in patients with postlingual sensorineural hearing loss accompanied by vestibular lesion.
    Mielczarek M; Olszewski J; Pietkiewicz P
    Arch Med Sci; 2018 Apr; 14(3):625-628. PubMed ID: 29765451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Sensitivity and Concordance of Machine-learning Tools for Diagnosing DFNA9 in a Large Series of p.Pro51Ser Variant Carriers in the COCH-gene.
    Salah M; de Varebeke SJ; Fransen E; Topsakal V; Van Camp G; Van Rompaey V
    Otol Neurotol; 2021 Jun; 42(5):671-677. PubMed ID: 33492061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced changes in protein compared to mRNA levels across non-proliferating tissues.
    Perl K; Ushakov K; Pozniak Y; Yizhar-Barnea O; Bhonker Y; Shivatzki S; Geiger T; Avraham KB; Shamir R
    BMC Genomics; 2017 Apr; 18(1):305. PubMed ID: 28420336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COCH predicts survival and adjuvant TACE response in patients with HCC.
    Wang C; Ding ZW; Zheng CG; Wang S; Li ZH; Zhang ZM; Pan J; Wang J; Yang C
    Oncol Lett; 2021 Apr; 21(4):275. PubMed ID: 33732351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic value of cochlin-tomoprotein in perilymphatic fistula].
    Xiong X; Yu J; Sun Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Sep; 34(9):857-861. PubMed ID: 33040516
    [No Abstract]   [Full Text] [Related]  

  • 13. Does Otovestibular Loss in the Autosomal Dominant Disorder DFNA9 Have an Impact of on Cognition? A Systematic Review.
    De Belder J; Matthysen S; Claes AJ; Mertens G; Van de Heyning P; Van Rompaey V
    Front Neurosci; 2017; 11():735. PubMed ID: 29375286
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a rare COCH mutation by whole-exome sequencing : Implications for personalized therapeutic rehabilitation in an Austrian family with non-syndromic autosomal dominant late-onset hearing loss.
    Parzefall T; Frohne A; Koenighofer M; Kirchnawy A; Streubel B; Schoefer C; Gstoettner W; Frei K; Lucas T
    Wien Klin Wochenschr; 2018 May; 130(9-10):299-306. PubMed ID: 28733840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression associated with the onset of hearing detected by differential display in rat organ of Corti.
    Reisinger E; Meintrup D; Oliver D; Fakler B
    Eur J Hum Genet; 2010 Dec; 18(12):1327-32. PubMed ID: 20648058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochlin isoforms and their interaction with CTL2 (SLC44A2) in the inner ear.
    Kommareddi PK; Nair TS; Raphael Y; Telian SA; Kim AH; Arts HA; El-Kashlan HK; Carey TE
    J Assoc Res Otolaryngol; 2007 Dec; 8(4):435-46. PubMed ID: 17926100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of full-length Cochlin p63s is inner ear specific.
    Li L; Ikezono T; Watanabe A; Shindo S; Pawankar R; Yagi T
    Auris Nasus Larynx; 2005 Sep; 32(3):219-23. PubMed ID: 15885953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cochlin mRNA splice variants in the inner ear.
    Sekine K; Ikezono T; Matsumura T; Shindo S; Watanabe A; Li L; Pawankar R; Nishino T; Yagi T
    Audiol Neurootol; 2010; 15(2):88-96. PubMed ID: 19657184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cochlin in the vestibular organ of rats.
    Ikezono T; Shindo S; Ishizaki M; Li L; Tomiyama S; Takumida M; Pawankar R; Watanabe A; Saito A; Yagi T
    ORL J Otorhinolaryngol Relat Spec; 2005; 67(5):252-8. PubMed ID: 16374056
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.